• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer

    Coloplast Launches New Catheter in the U.S.

    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors

    NAMSA Relaunches Medtech Outsourcing Solution

    Rollomatic Inc. Welcomes Joe Kane as CEO
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Sales Tips for Contract Manufacturers of Finished Devices

    Evolving trends in the supply chain may require companies to consider a strategy of selling devices of their own design.

    Sales Tips for Contract Manufacturers of Finished Devices
    Related CONTENT
    • Robling Medical Inc.
    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • B. Braun's OEM Division, B. Braun Medical Inc.
    • Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500 Million Last Year
    • 7. Cardinal Health
    Tony Freeman, President, A.S. Freeman Advisors LLC11.04.19
    Many medical device supply chain companies have expanded beyond their traditional manufacturing capabilities to include device design, engineering, and regulatory services. With the goal of capturing more content on a given device, these contract manufacturers have unconsciously begun to mirror the structure of the OEMs they serve. Deliberately or not, these firms find themselves capable of designing and building complete medical devices independent of an OEM customer. While the profits of selling a finished device to end-users may be attractive, there are notable commercial and financial risks to be considered. Yet, evolving trends in the supply chain may require companies to consider a strategy of selling devices of their own design.

    To Be or Not To Be?
    In recent years, contract manufacturers (CMs) specializing in components have invested heavily in staff and equipment to boost their offering to include the design and manufacture of complete devices. The logic for these notable efforts is clear—CMs capable of creating and building a complete device stand a better chance of landing large projects from their OEM customers. Invariably the managers of these firms are beset by a nagging question. If a firm can design, pass regulatory, build, assemble, and deliver a device, are there instances where it might be vastly more profitable to sell the product directly than go through an OEM? The answer is yes but the path is risky.

    The economic incentive for direct sales of medical devices is clear. A quick look at the income statements of publicly traded OEMs show gross margins between 60 percent and 70 percent vs. comparable margins ranging from 20 percent to 40 percent for contract manufacturers. Even adding the cost of research and development (around 8 percent on average for established OEMs) and higher sales and marketing expenses, direct sales of finished products delivers more than 20 percent more in margin than contract manufacturing.  Additionally, a CM bringing a product to market is likely to recognize revenue sooner, as they can often go to market more quickly than an OEM customer slowed by internal product strategy decisions and coordination with global sales teams.

    Common Strategies
    CMs willing to make the leap to selling a complete product for which they own the intellectual property have generally relied on one of two strategies to reach the end-user. The first is private labeling, also called white labeling. In a private labeling model, the CM self-designs and develops a product it thinks fills a need in the market. After obtaining a 510(k) and building prototypes, the CM approaches OEMs to sell the product to end-use customers. The CM manufactures the device but marks and labels the product as if it were the OEM’s own. An example from another industry may help clarify the model. Private labeling is common in store brands found in a supermarket. Though the item is sold under the store’s own brand, it is manufactured in another company’s facility and simply labeled as the store’s own. Private labeling routinely brings higher margins than traditional contract manufacturing because the CM has absorbed all costs of development and owns the intellectual property. From the OEM’s perspective, it is a simple way to fill holes in a product or enhance an existing offering. Still, as the OEM is incurring the cost of marketing and sales, CMs should expect to share with the OEM a minimum of 20 percent to 30 percent of the end-use selling price. Private labeled products may be sold through a single OEM or several, depending on the product, its uniqueness, and market need. Cardinal Health and Medline are among the OEMs most committed to selling private labeled products.

    The second strategy is a branded offering. Under this strategy, the CM bypasses OEMs and takes the self-designed product to market directly. In essence, a CM choosing this approach becomes an OEM. There is opportunity to recognize OEM-level margins but to do so, the CM will have to add a sales team capable of selling to hospital buying groups, physicians practices, and device catalog firms. CMs choosing this route often separately brand their directly sold product from their contract manufacturing services using a different name and logo.

    Pros and Cons
    Selling either private labeled or branded products offers CMs more than higher profit margins. The lifecycle of a device averages from five to 15 years, depending on the type of device and the area of medicine it serves. The long life of devices ensures steady revenues, particularly for successful products. Another benefit is that selling a company’s own IP broadens the number and type of customers with which it comes in contact. In an era of consolidating supply chains, a richer customer base has special value. A final point is that profits associated with the sale of a company’s own intellectual property or brand have a valuation multiple two to three times that of contract manufacturing.

    While financially and commercially lucrative, selling private label or branded products carries risks. The first and most obvious issue is channel conflict. For those not familiar with the term, channel conflict is a formal designation for “competing with your customer.” OEMs rightly question suppliers who seek to offer products directly to end-use customers or through private labeling deals with competitors. Core contract manufacturing work may end up at risk. It is critical to review plans with current customers to ensure the two companies are not competing for the same end-user dollar.

    Besides possible conflicts with customers, private labeling and the direct sale of a branded product bring other challenges. Most devices have a long sales cycle, requiring the developer to fund design, engineering, regulatory efforts, and missionary sales for an extended period. Additionally, many useful products fail to commercialize due to an oversupply of established, competing products or the developer’s inability to organize a sales effort that is sharply different from those used for contracting manufacturing projects.

    Critical Success Factors
    A contract manufacturer that decides to offer private label or branded devices needs a different set of skills than those required to make a product for another company. Most CMs pride themselves on their manufacturing excellence and reliable quality. Product success depends on identification of a market need, a discipline not frequently found among contract manufacturing companies. Too often, firms hoping to launch a product assume a few superior features will be sufficient to catapult the product to success. A product that is marginally better than existing items on the market does not guarantee customers. Rather, success requires either a demonstrably superior product in terms of outcomes or identification of a hole in a specific OEM(s) product line.

    Strong market insight is not the only requirement. Money matters. A CM selling its own product will require sufficient capital to complete development and get through regulatory approval. Additionally, the sales cycles for a device can take years, requiring additional funding for a potentially long period of missionary selling. Another wrinkle is that sales people experienced with selling contract manufacturing projects may lack the contacts and knowledge to sell finished devices. A separate sales team could be required, one that brings in revenue for an extended period.

    Is it necessity for companies to consider selling their own devices? Not at this time, though the future may be different. Contract manufacturers are wrestling with the dual threats of OEM consolidation and the entry of large, global electronics CMs into medical manufacturing. A CM’s direct relationships with large OEMs may decline or be constrained. If sufficient work can not be obtained through traditional channels, CMs must consider alternative strategies to deploy their design/manufacturing capabilities. Some will likely choose to offer finished devices should desirable contract manufacturing work become less available.

    How to Decide
    Moving to finished devices is a major shift in strategy for firms focused on contract manufacturing. In evaluating any transition of this scale, it is recommended that “no change” is the default position. A company electing to take on finished devices should have a clear path to success that addresses channel conflict, a strong product strategy, funding, and missionary sales efforts. Until these aspects of this transformational strategy are in place, it is unwise to take steps that may leave a firm uncomfortably between the world of contract manufacturing and the world of finished devices. 


    Tony Freeman is president of A.S. Freeman Advisors LLC, an advisor on mergers and acquisitions in the specialty materials and precision manufacturing markets. Based in New York City, A.S. Freeman Advisors also provides corporate strategy, market planning, and valuation improvement consulting services. Freeman can be contacted at tfreeman@asfreeman.com.
    Related Searches
    • it
    • electronics
    • change
    • president
    Related Knowledge Center
    • Contract Manufacturing
    Suggested For You
    Robling Medical Inc. Robling Medical Inc.
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    B. Braun B. Braun's OEM Division, B. Braun Medical Inc.
    Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500 Million Last Year Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500 Million Last Year
    7. Cardinal Health 7. Cardinal Health
    Grover Precision Fills Key Positions Grover Precision Fills Key Positions
    Assembling with Reliability and Repeatability Through Automation Assembling with Reliability and Repeatability Through Automation
    J&J-Jabil Deal Truly Is Transformative for the Medtech Supply Chain J&J-Jabil Deal Truly Is Transformative for the Medtech Supply Chain
    ICU Medical CFO Announces Retirement After Close of FY19 ICU Medical CFO Announces Retirement After Close of FY19
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    7. Cardinal Health 7. Cardinal Health
    7. Siemens Healthineers 7. Siemens Healthineers
    22. Dentsply Sirona 22. Dentsply Sirona
    Turning a Regulatory Headache into a Competitive Advantage Turning a Regulatory Headache into a Competitive Advantage
    Cardinal Health Appoints New Medical Segment CEO Cardinal Health Appoints New Medical Segment CEO

    Related Buyers Guide Companies

    • Robling Medical Inc.

      Robling Medical Inc.

      ...
      Jim Schoeplein, New Business Development Manager 10.05.22

    • 3D/Additive Manufacturing
      Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

      Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

      As printers, materials, and know-how continue to advance, additive manufacturing and 3D printing offer production-ready functionality for device makers.
      Mark Crawford, Contributing Writer 11.04.19

    • B. Braun

      B. Braun's OEM Division, B. Braun Medical Inc.

      Drawing on a legacy of healthcare innovation spanning over 160 years, the B. Braun OEM Division offers the knowledge and capabilities to provide a wide range of products and contract manufacturing services.
      Maris Stern, Communication Strategist 10.07.19


    • Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500 Million Last Year

      Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500 Million Last Year

      Hospital uptake of commercial medical device reprocessing doubled yearly for the last 20 years, according to report.
      Globe Newswire 09.20.19

    • Cardiovascular | Diagnostics | Digital Health | Neurological | Patient Monitoring | Surgical
      7. Cardinal Health

      7. Cardinal Health

      Highlights from one of the number seven spot holders of MPO's Top 30 Global Medical Device Companies report.
      Michael Barbella, Managing Editor

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • Coloplast Launches New Catheter In The U.S.
    • A New Approach To Post-Market Surveillance
    Breaking News
    • The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    • Coloplast Launches New Catheter in the U.S.
    • Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    • NAMSA Relaunches Medtech Outsourcing Solution
    • Rollomatic Inc. Welcomes Joe Kane as CEO
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    CRN Announces Promotions and Welcomes New Staff Member
    Quercetin Ingredient Linked to Improved COVID-19 Recovery: Study
    Coatings World

    Latest Breaking News From Coatings World

    PPG Achieves ISO 14001 Certification of Environmental Management System
    AmCoat’s Rhino Shield and Floor Shield Break Records in 2022
    Automotive Industry Leaders Form Cofinity-X JV
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    Coloplast Launches New Catheter in the U.S.
    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Jones Healthcare Group Installs BOBST NOVACUT 106 ER Flatbed Die-Cutter
    Pfizer Revenues Soar to Record-Breaking $100B in 2022
    iuvo BioScience Appoints Industry Exec to Lead Lab Biz
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pacifica is our Packager of the Year
    La Roche-Posay Named the Fastest Growing Skincare Brand of 2022 by NielsenIQ
    Disney Collaborates with Nailtopia on Limited-Edition Nail Collection
    Happi

    Latest Breaking News From Happi

    Color Street Launches ‘Through the Cosmos’ Collection
    Curl Care Collection is New at Native
    Color Street Pledges $100K To Support Military & Veteran Appreciation
    Ink World

    Latest Breaking News From Ink World

    International Paper Reports Full-Year, 4Q 2022 Results
    UFlex Exhibits Sustainable Printing, Packaging Solutions at Plast India 2023
    Early-Bird Registration Opens for Print UV 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC announces value chain partnerships
    Digital Embellishment Alliance launches new website community
    FLAG achieves record membership in 2022
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Superior Felt & Filtration Adds Domestic Injection Molding to its Medical Filtration Capabilities
    Ahlstrom Launches New Generation FluoroFree Technology
    Berry to Begin Production at India Healthcare Hub Early This Year
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    ODT's Most-Read Stories This Week—Jan. 28
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Johan Hjertonsson Proposed as New Chairman of ASSA ABLOY
    Durak Highlights SilverPro Conductive Threads
    Arkema Partners with Research Institute to Open Lab in Mulhouse, France

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login